Reply: 3,4-diaminopyridine in LEMS: Concerns regarding presentation of previous studies
dc.contributor.author | Sanders, Donald B. | |
dc.contributor.author | Harati, Yadollah | |
dc.contributor.author | Juel, Vern C. | |
dc.contributor.author | Lou, Jau-Shin | |
dc.contributor.author | Marburger, Tessa | |
dc.contributor.author | Pascuzzi, Robert M. | |
dc.contributor.author | Peltier, Amanda C. | |
dc.contributor.author | Richman, David P. | |
dc.contributor.author | Smith, A. Gordon | |
dc.contributor.department | Neurology, School of Medicine | en_US |
dc.date.accessioned | 2018-03-07T15:41:40Z | |
dc.date.available | 2018-03-07T15:41:40Z | |
dc.date.issued | 2018 | |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Sanders, D. B., Harati, Y., Juel, V. C., Lou, J.-S., Marburger, T., Pascuzzi, R. M., Peltier, A. C., Richman, D. P. and Smith, A. G. (2018), Reply: 3,4-Diaminopyridine in LEMS: Concerns regarding presentation of previous studies. Muscle Nerve. Accepted Author Manuscript. http://dx.doi.org/10.1002/mus.26089 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/15385 | |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.isversionof | 10.1002/mus.26089 | en_US |
dc.relation.journal | Muscle Nerve | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | Author | en_US |
dc.subject | Lambert-Eaton myasthenia | en_US |
dc.subject | 3,4-diaminopyridine | en_US |
dc.subject | DAPPER | en_US |
dc.title | Reply: 3,4-diaminopyridine in LEMS: Concerns regarding presentation of previous studies | en_US |
dc.type | Article | en_US |